
Admit Pharmaceuticals Private Limited
About Admit Pharmaceuticals Private Limited
Data last updated:
Admit Pharmaceuticals Private Limited is a private limited company based in Ahmedabad, Gujarat, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 24 March 2005 and has been in existence for over 21 years.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U24230GJ2005PTC045758. Its GSTIN is 24AAFCA1483P1ZF (Gujarat).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹9.1 Lakh. It is led by directors Mahesh Ghughabhai Paradava and Mehul Babubhai Katariya.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Ll/3 Basement Man Sarovar Near Octroi Naka Nikol Gam Road Nikol, Ahmedabad, Gujarat, India – 380051.
As per the financials filed for FY 2024, the company reported a revenue of ₹6.97 Lakh, a decline of 14% compared to the previous year. For the same year it recorded a net loss of ₹42,470 (net margin -6.1%) and EBITDA of -₹2,227 (EBITDA margin -0.3%). Revenue has declined at a compounded annual rate (CAGR) of 41% over three years and 7% over five years.
As per MCA filings, the company has satisfied charges of ₹54.5 Lakh on record.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressLl/3 Basement Man Sarovar Near Octroi Naka Nikol Gam Road Nikol, Ahmedabad, Gujarat, India – 380051
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Admit Pharmaceuticals Private Limited
The main business activity of Admit Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Admit Pharmaceuticals Private Limited FY 2025 filings available
Admit Pharmaceuticals Private Limited reported revenue of ₹6.97 Lakh (down 14% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR) of Admit Pharmaceuticals Private Limited
Revenue has declined at a compounded annual rate (CAGR) of 7% over five years, including a 14% fall in the latest year. EBITDA fell 131% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Admit Pharmaceuticals Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | -₹2,227 | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹42,470 | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Admit Pharmaceuticals Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -0.3% | •••• | •••• | •••• | •••• |
| Net Profit Margin | -6.1% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Admit Pharmaceuticals are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Admit Pharmaceuticals Private Limited
Admit Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Saniance Pharmaceuticals Private Limited | ₹7 Lakh (FY 2025) | •••• | •••• | 31.0% | •••• | Bangalore, Karnataka, India |
| Meridian Lifecare Private Limited | ₹6.99 Lakh (FY 2024) | •••• | •••• | -12.0% | •••• | Ambedkar Path Khajpura, Bihar, India |
| Bless Med (India) Private Limited | ₹6.99 Lakh (FY 2025) | •••• | •••• | -85.0% | •••• | Navi Mumbai, Maharashtra, India |
| Vanin Pharmaceuticals Private Limited | ₹6.99 Lakh (FY 2024) | •••• | •••• | •••• | Vejalpur, Gujarat, India | |
| Rxsum Pharmaceuticals Private Limited | ₹6.98 Lakh (FY 2017) | •••• | •••• | •••• | Jaipur, Rajasthan, India | |
| Admit Pharmaceuticals Private Limited this company | ₹6.97 Lakh (FY 2024) | •••• | •••• | -14.0% | •••• | Ahmedabad, Gujarat, India |
| Welcure Pharmaceuticals Private Limited | ₹6.93 Lakh (FY 2024) | •••• | •••• | 52.0% | •••• | New Delhi, Delhi, India |
| Smithson Pharmaceuticals India Private Limited | ₹6.93 Lakh (FY 2024) | •••• | •••• | -14.0% | •••• | Indore, Madhya Pradesh, India |
| Puramill Pharmx Private Limited | ₹6.93 Lakh (FY 2023) | •••• | •••• | -85.0% | •••• | Vadodara, Gujarat, India |
| Eravic Pharmaceuticals Private Limited | ₹6.91 Lakh (FY 2021) | •••• | •••• | 111.0% | •••• | Lucknow, Uttar Pradesh, India |
| Satmat Pharma Private Limited | ₹6.91 Lakh (FY 2024) | •••• | •••• | •••• | Pune, Maharashtra, India |
Peers are the five companies nearest above and the five nearest below Admit Pharmaceuticals by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Admit Pharmaceuticals Private Limited
Admit Pharmaceuticals Private Limited is audited by NIRAV S SHAH & CO for the financial year 2018.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| NIRAV S SHAH & CO | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Admit Pharmaceuticals Private Limited
Admit Pharmaceuticals has 2 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Mahesh Ghughabhai Paradava | Director | 25 Jul 2015 | 11 Years 2 Months | Current |
| Mehul Babubhai Katariya | Director | 28 Mar 2013 | 13 Years 6 Months | Current |
Ownership and Shareholding of Admit Pharmaceuticals Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Admit Pharmaceuticals Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 05 Jul 2010 | Indian Bank | ₹22 Lakh | Satisfied |
| 25 Mar 2009 | Vijay Commercialco-Operative Bank Limited | ₹20 Lakh | Satisfied |
| 11 May 2006 | Vijay Commercial Co-Operative Bank Limited | ₹12.5 Lakh | Satisfied |
Total charge records: 3 View all charges
Employees and EPFO Compliance at Admit Pharmaceuticals Private Limited
Employment history and EPFO contributions of people linked to Admit Pharmaceuticals.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Admit Pharmaceuticals Private Limited
Admit Pharmaceuticals Private Limited has 6 board changes on record since 2010: 2 appointments and 4 cessations. The latest: Mahesh Ghughabhai Paradava was appointed as Director on 25 Jul 2015.
3 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Admit Pharmaceuticals Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Admit Pharmaceuticals Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Admit Pharmaceuticals Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Admit Pharmaceuticals Private Limited
Admit Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24AAFCA1483P1ZF | Gujarat | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Admit Pharmaceuticals Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Admit Pharmaceuticals Private Limited
Admit Pharmaceuticals is an active private limited company based in Ahmedabad, Gujarat, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 24 March 2005 (21+ years old) and is registered under CIN U24230GJ2005PTC045758.
Admit Pharmaceuticals reported revenue of ₹6.97 Lakh for FY 2024 (down 14% YoY).
Admit Pharmaceuticals has 2 current directors:
- Mahesh Ghughabhai Paradava - Director
- Mehul Babubhai Katariya - Director
Admit Pharmaceuticals reported a net loss of ₹42,470 (net margin -6.1%) and EBITDA of -₹2,227 (EBITDA margin -0.3%) for FY 2024, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Admit Pharmaceuticals is -41% over three years and -7% over five years. In the latest year (FY 2024) revenue fell 14%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Admit Pharmaceuticals is 24AAFCA1483P1ZF, registered in Gujarat.
The CIN (Corporate Identification Number) of Admit Pharmaceuticals is U24230GJ2005PTC045758. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Admit Pharmaceuticals was incorporated on 24 March 2005, making it 21+ years old. It is registered with the Registrar of Companies, Ahmedabad.
The peers of Admit Pharmaceuticals by revenue are Saniance Pharmaceuticals Private Limited, Meridian Lifecare Private Limited, Bless Med (India) Private Limited, Vanin Pharmaceuticals Private Limited, Rxsum Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals).
Mahesh Ghughabhai Paradava was appointed as Director on 25 Jul 2015. Mayur Kanjibhai Katariya ceased to be Director on 25 Jul 2015. Hareshbhai Sevakram Panjwani ceased to be Director on 30 Mar 2013. Admit Pharmaceuticals has 6 board changes on record in total.
The registered office of Admit Pharmaceuticals is at Ll3 Basement Man Sarovar Near Octroi Naka Nikol Gam Road Nikol, Ahmedabad, Gujarat, India – 380051.